| 注册
首页|期刊导航|郑州大学学报(医学版)|妇科恶性肿瘤患者 TC 方案化疗后发生重度骨髓抑制的影响因素

妇科恶性肿瘤患者 TC 方案化疗后发生重度骨髓抑制的影响因素

徐西岳 朱新群 刘小静

郑州大学学报(医学版)2016,Vol.51Issue(5):657-660,4.
郑州大学学报(医学版)2016,Vol.51Issue(5):657-660,4.DOI:10.13705/j.issn.1671-6825.2016.05.026

妇科恶性肿瘤患者 TC 方案化疗后发生重度骨髓抑制的影响因素

Related factors of severe bone marrow suppression of patients with gyne-cologic malignant tumor after chemotherapy with TC program

徐西岳 1朱新群 1刘小静1

作者信息

  • 1. 郑州大学第二附属医院妇产科郑州450014
  • 折叠

摘要

Abstract

Aim:To research the related factors of severe bone marrow suppression occurred within 3-4 days after the chemotherapy with paclitaxel and nedaplatin( TC program) in patients with gynecologic malignant tumor.Methods:A total of 118 patients with gynecologic malignant tumor were treated with TC chemotherapy,among whom, 58 developed grade 0 toⅠbone marrow suppression( mild group) ,and 60 developed gradeⅡorⅢorⅣbone marrow suppression( severe group) . The relationship between related factors such as age, body mass index, body surface area, internal medicine amalgamative disease, tumor staging, chemotherapy course, tumor type and severe bone marrow suppression after chemotherapy was ana-lyzed by single factor analysis.The influencing factors of severe bone marrow suppression were analyzed by logistic regres-sion analysis.Results:Univariate analysis showed that age, tumor type, tumor stage, chemotherapy course were related to severe bone marrow depression ( P <0.05 ) .Logistic regression analysis showed that cervical cancer, tumor stage, and chemotherapy course were related to severe bone marrow depression(OR=0.046,2.357,3.121,P<0.05).Conclusion:Late stage of tumor, number of chemotherapy course are the risk factors for the occurrence of severe bone marrow suppres-sion;the patients with cervical cancer have lower risk of developing severe bone marrow suppression than those with ovarian cancer.

关键词

妇科恶性肿瘤/紫杉醇/奈达铂/化疗/重度骨髓抑制

Key words

gynecologic malignant tumor/paclitaxel/nedaplatin/chemotherapy/severe bone marrow suppression

分类

医药卫生

引用本文复制引用

徐西岳,朱新群,刘小静..妇科恶性肿瘤患者 TC 方案化疗后发生重度骨髓抑制的影响因素[J].郑州大学学报(医学版),2016,51(5):657-660,4.

郑州大学学报(医学版)

OA北大核心CSTPCD

1671-6825

访问量0
|
下载量0
段落导航相关论文